{"id":"https://openalex.org/W2339660487","doi":"https://doi.org/10.1158/1538-7445.am2015-2529","title":"Abstract 2529: Debio 1143 synergizes with taxanes, topoisomerase and bromodomain inhibitors to inhibit growth of lung adenocarcinoma","display_name":"Abstract 2529: Debio 1143 synergizes with taxanes, topoisomerase and bromodomain inhibitors to inhibit growth of lung adenocarcinoma","publication_year":2015,"publication_date":"2015-08-01","ids":{"openalex":"https://openalex.org/W2339660487","doi":"https://doi.org/10.1158/1538-7445.am2015-2529","mag":"2339660487"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2015-2529","doi":"https://doi.org/10.1158/1538-7445.am2015-2529","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2015-2529","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026440661","display_name":"Casey G. Langdon","orcid":"https://orcid.org/0000-0002-0010-7209","observed_orcids":["https://orcid.org/0000-0002-0010-7209"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Casey G. Langdon","raw_affiliation_strings":["1Yale University, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006648592","display_name":"Norbert Wiedemann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095057","display_name":"Debiopharm (Switzerland)","ror":"https://ror.org/00nxzrk14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210095057"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Norbert Wiedemann","raw_affiliation_strings":["2Debiopharm International, Lausanne, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Debiopharm International, Lausanne, Switzerland;","institution_ids":["https://openalex.org/I4210095057"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110079029","display_name":"Matthew A. Held","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew A. Held","raw_affiliation_strings":["1Yale University, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074871482","display_name":"James T. Platt","orcid":"https://orcid.org/0000-0002-4286-446X","observed_orcids":["https://orcid.org/0000-0002-4286-446X"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James T. Platt","raw_affiliation_strings":["1Yale University, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044683657","display_name":"Ramanaiah Mamillapalli","orcid":"https://orcid.org/0000-0002-4022-8910","observed_orcids":["https://orcid.org/0000-0002-4022-8910"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramanaiah Mamillapalli","raw_affiliation_strings":["1Yale University, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036912950","display_name":"Pinar Iyidogan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pinar Iyidogan","raw_affiliation_strings":["1Yale University, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023093211","display_name":"Nicholas Theodosakis","orcid":"https://orcid.org/0000-0003-4388-2288","observed_orcids":["https://orcid.org/0000-0003-4388-2288"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Theodosakis","raw_affiliation_strings":["1Yale University, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113486446","display_name":"Fr\u00e9d\u00e9ric L\u00e9vy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095057","display_name":"Debiopharm (Switzerland)","ror":"https://ror.org/00nxzrk14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210095057"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Frederic Levy","raw_affiliation_strings":["2Debiopharm International, Lausanne, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Debiopharm International, Lausanne, Switzerland;","institution_ids":["https://openalex.org/I4210095057"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047788852","display_name":"Denis Robichon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095057","display_name":"Debiopharm (Switzerland)","ror":"https://ror.org/00nxzrk14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210095057"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Denis Robichon","raw_affiliation_strings":["2Debiopharm International, Lausanne, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Debiopharm International, Lausanne, Switzerland;","institution_ids":["https://openalex.org/I4210095057"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084431593","display_name":"Claudio Zanna","orcid":"https://orcid.org/0009-0001-8001-2065","observed_orcids":["https://orcid.org/0009-0001-8001-2065"]},"institutions":[{"id":"https://openalex.org/I4210095057","display_name":"Debiopharm (Switzerland)","ror":"https://ror.org/00nxzrk14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210095057"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Claudio Zanna","raw_affiliation_strings":["2Debiopharm International, Lausanne, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Debiopharm International, Lausanne, Switzerland;","institution_ids":["https://openalex.org/I4210095057"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904841","display_name":"Gr\u00e9goire Vuagniaux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095057","display_name":"Debiopharm (Switzerland)","ror":"https://ror.org/00nxzrk14","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210095057"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Gregoire Vuagniaux","raw_affiliation_strings":["2Debiopharm International, Lausanne, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Debiopharm International, Lausanne, Switzerland;","institution_ids":["https://openalex.org/I4210095057"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109216776","display_name":"Mel Sorensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mel Sorensen","raw_affiliation_strings":["3Ascenta Therapeutics, Malvern, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Ascenta Therapeutics, Malvern, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073754378","display_name":"Shaomeng Wang","orcid":"https://orcid.org/0000-0002-8782-6950","observed_orcids":["https://orcid.org/0000-0002-8782-6950"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaomeng Wang","raw_affiliation_strings":["4University of Michigan, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4University of Michigan, Ann Arbor, MI","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076813249","display_name":"Marcus Bosenberg","orcid":"https://orcid.org/0000-0003-0166-1612","observed_orcids":["https://orcid.org/0000-0003-0166-1612"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcus W. Bosenberg","raw_affiliation_strings":["1Yale University, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009455412","display_name":"David F. Stern","orcid":"https://orcid.org/0000-0003-4018-5348","observed_orcids":["https://orcid.org/0000-0003-4018-5348"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David F. Stern","raw_affiliation_strings":["1Yale University, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Yale University, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"75","issue":"15_Supplement","first_page":"2529","last_page":"2529"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/smac-mimetics","display_name":"IAP antagonists","score":0.8840000033378601},{"id":"https://openalex.org/keywords/lung-adenocarcinoma","display_name":"lung adenocarcinoma","score":0.9700000286102295},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.8270000219345093},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.7770000100135803},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9929999709129333},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9990000128746033},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5839999914169312},{"id":"https://openalex.org/keywords/ripoptosome","display_name":"ripoptosome","score":0.8659999966621399},{"id":"https://openalex.org/keywords/inhibitor-of-apoptosis-proteins","display_name":"inhibitor of apoptosis proteins","score":0.8050000071525574},{"id":"https://openalex.org/keywords/ciap1","display_name":"cIAP1","score":0.8220000267028809},{"id":"https://openalex.org/keywords/ciap2","display_name":"cIAP2","score":0.9570000171661377},{"id":"https://openalex.org/keywords/xiap","display_name":"XIAP","score":1.0},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.9139999747276306}],"concepts":[{"id":"https://openalex.org/C33195913","wikidata":"https://www.wikidata.org/wiki/Q20970121","display_name":"XIAP","level":5,"score":0.6802754998207092},{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.5765906572341919},{"id":"https://openalex.org/C2777408456","wikidata":"https://www.wikidata.org/wiki/Q174299","display_name":"Inhibitor of apoptosis","level":4,"score":0.48454490303993225},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.43102139234542847},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42059195041656494},{"id":"https://openalex.org/C172512520","wikidata":"https://www.wikidata.org/wiki/Q5768379","display_name":"Hippo signaling pathway","level":3,"score":0.418678343296051},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41466134786605835},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41392451524734497},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.40304452180862427},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39234524965286255},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.35921114683151245},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25067663192749023},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1821098029613495},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14153960347175598},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.11226260662078857},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08734706044197083},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.08087241649627686},{"id":"https://openalex.org/C98424977","wikidata":"https://www.wikidata.org/wiki/Q25805","display_name":"Caspase","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2015-2529","doi":"https://doi.org/10.1158/1538-7445.am2015-2529","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2015-2529","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1877251089","https://openalex.org/W2108816479","https://openalex.org/W1979037321","https://openalex.org/W2406077881","https://openalex.org/W1540485610","https://openalex.org/W2954629192","https://openalex.org/W1540992897","https://openalex.org/W2034535412","https://openalex.org/W2323484115","https://openalex.org/W2170823959"],"abstract_inverted_index":{"Abstract":[0],"Efficient":[1],"induction":[2],"of":[3,10,26,33,80,94,133,138,165,181,214,217,310,316,321],"cell":[4,158,184],"death":[5],"is":[6,39,74],"essential":[7],"for":[8,105,256,325],"efficacy":[9],"cancer":[11,58],"therapies,":[12],"and":[13,54,121,126,146,194,197,229,241,304],"may":[14,244],"be":[15],"enhanced":[16],"in":[17,47,50,56,70,85,116,226],"combination":[18,51,68,117,132,188],"therapies":[19],"that":[20,91,110,236],"promote":[21],"apoptosis.":[22],"Small":[23],"molecule":[24],"mimetics":[25],"the":[27,127,166,171,187,199,205,237,317,322],"pro-apoptotic":[28],"protein":[29,179],"SMAC":[30,43,257],"antagonize":[31],"Inhibitor":[32],"Apoptosis":[34],"Proteins":[35],"(IAPs).":[36],"Debio":[37,72,100,111,134,156,160,175,218,242,298],"1143":[38,73,101,112,135,161,176,219,243,299],"a":[40,63,78],"potent":[41],"oral":[42],"mimetic":[44,258],"currently":[45],"assessed":[46],"clinical":[48],"trials":[49],"with":[52,77,118,136,189,220,301],"chemo-":[53],"radiotherapy":[55],"different":[57,250],"indications.":[59],"We":[60,108],"have":[61],"conducted":[62],"\u201cone":[64],"vs.":[65],"many\u201d":[66],"drug":[67,89],"screen":[69],"which":[71],"combined":[75],"pairwise":[76],"panel":[79],"128":[81],"candidate":[82],"partner":[83],"agents":[84,140],"order":[86],"to":[87,252,307],"identify":[88],"combinations":[90,102,216],"inhibit":[92,308],"growth":[93,115,309],"lung":[95,227,311],"adenocarcinoma":[96,228],"cells.":[97],"Several":[98],"synergistic":[99],"were":[103],"selected":[104],"further":[106,141],"analysis.":[107],"confirmed":[109],"synergistically":[113],"inhibited":[114,142,198],"taxanes":[119],"paclitaxel":[120],"docetaxel,":[122],"topoisomerase":[123,303],"inhibitor":[124,129],"SN-38,":[125],"bromodomain":[128,224,305],"JQ1.":[130],"The":[131],"any":[137],"these":[139,210,233],"clonogenic":[143],"colony":[144],"formation":[145,164],"induced":[147,163],"apoptosis":[148],"more":[149],"than":[150],"either":[151],"agent":[152],"alone.":[153],"In":[154],"two":[155],"1143-sensitive":[157],"lines":[159],"also":[162,191],"cell-death":[167],"inducing":[168,204],"complex":[169],"-":[170],"ripoptosome.":[172],"Interestingly,":[173],"while":[174,203],"broadly":[177],"reduced":[178,192],"levels":[180,196,251],"cIAP1":[182],"across":[183],"lines,":[185],"specifically":[186],"JQ1":[190,240,247],"cIAP2":[193],"XIAP":[195],"canonical":[200],"NF-\u03baB":[201,207],"pathway":[202],"non-canonical":[206],"pathway.":[208],"Overall,":[209],"data":[211],"support":[212],"utility":[213],"several":[215],"other":[221,230],"agents,":[222],"especially":[223],"inhibitors,":[225],"cancers.":[231],"Specifically,":[232],"findings":[234],"indicate":[235],"synergy":[238],"between":[239],"derive":[245],"from":[246],"contributing":[248],"on":[249],"key":[253],"mechanisms":[254],"relevant":[255],"antitumor":[259],"activity.":[260],"Citation":[261],"Format:":[262],"Casey":[263],"G.":[264],"Langdon,":[265],"Norbert":[266],"Wiedemann,":[267],"Matthew":[268],"A.":[269],"Held,":[270],"James":[271],"T.":[272],"Platt,":[273],"Ramanaiah":[274],"Mamillapalli,":[275],"Pinar":[276],"Iyidogan,":[277],"Nicholas":[278],"Theodosakis,":[279],"Frederic":[280],"Levy,":[281],"Denis":[282],"Robichon,":[283],"Claudio":[284],"Zanna,":[285],"Gregoire":[286],"Vuagniaux,":[287],"Mel":[288],"Sorensen,":[289],"Shaomeng":[290],"Wang,":[291],"Marcus":[292],"W.":[293],"Bosenberg,":[294],"David":[295],"F.":[296],"Stern.":[297],"synergizes":[300],"taxanes,":[302],"inhibitors":[306],"adenocarcinoma.":[312],"[abstract].":[313],"In:":[314],"Proceedings":[315],"106th":[318],"Annual":[319],"Meeting":[320],"American":[323],"Association":[324],"Cancer":[326,336],"Research;":[327],"2015":[328],"Apr":[329],"18-22;":[330],"Philadelphia,":[331],"PA.":[332],"Philadelphia":[333],"(PA):":[334],"AACR;":[335],"Res":[337],"2015;75(15":[338],"Suppl):Abstract":[339],"nr":[340],"2529.":[341],"doi:10.1158/1538-7445.AM2015-2529":[342]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}